Get insight from foundation experts on research, treatment and prevention, plus the very latest news and events.
Switch on your HIV smarts.
Hepatitis C is best known as an infection transmitted by blood, with most new cases of hepatitis C caused by sharing injection drug use equipment. But this dangerous infection, which … Read More
The U.S. Food and Drug Administration (FDA) has approved two new once-daily combination pills to treat all genotypes of hepatitis C virus (HCV). Gilead Sciences’ Vosevi (sofosbuvir/velpatasvir/voxilaprevir) was approved on … Read More
Long-acting antiretrovirals that could be used for both HIV treatment and prevention were among the big news at the International AIDS Society Conference on HIV Science, held last month in … Read More
Join us for daily news and commentary on HIV/AIDS treatment, prevention and policy.
The foundation's ongoing forum series bringing research and evidence to bear on timely policy and programmatic issues.